z-logo
Premium
Angiotensin‐converting enzyme gene insertion/deletion polymorphism and family history in severe acne vulgaris
Author(s) -
Sorour Neveen E.,
Mustafa Amany I.,
Alhusseni Naglaa F.,
Fawzy Eman,
Amer Aml G.
Publication year - 2019
Publication title -
journal of cosmetic dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.626
H-Index - 44
eISSN - 1473-2165
pISSN - 1473-2130
DOI - 10.1111/jocd.12937
Subject(s) - acne , gene , genetics , enzyme , medicine , angiotensin converting enzyme , polymorphism (computer science) , dermatology , biology , genotype , biochemistry , blood pressure
Summary Background Acne vulgaris is an inflammatory disorder with a profound heterogenous aetio‐pathophysiology. ACE gene I/D polymorphism affects angiotensin‐converting enzyme activities that play a role in inflammation. However, there are no molecular genetic studies investigating the contribution of ACE gene insertion/deletion polymorphism in the genetic background of acne vulgaris. Aims The aim of this work was to reveal the relation between the ACE gene I/D polymorphism and acne vulgaris development among a sample of patients. Patients and Methods This study included 100 acne vulgaris patients in addition to 120 matched control subjects. The ACE gene I/D polymorphism was analyzed using polymerase chain reaction (PCR). Results The distribution of DD, ID genotypes, and D allele showed higher frequency in AV patients than in controls ( P  < 0.001 for all). Moreover, positive family history and ACEI/D gene polymorphism (DD + ID genotypes) were considered as independent predictors for severe acne grades ( P  ≤ 0.001 and 0.046, respectively) in multivariate analysis. Conclusions The current study results suggest that the D allele of the ACE I/D gene polymorphism might confer risk to AV among the studied patients. Moreover, ACE I/D gene polymorphism and positive family history were considered as independent predictors of severe AV.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here